| |
|
|
|
vTv Therapeutics Inc.  
|
|
1.57 -0.02 (-0.01%) |
09-20 16:00 |
|
Open: |
1.61 |
Pre close: |
1.59 |
Target:
|
1.96
|
|
High: |
1.67 |
Low: |
1.44 |
Resistance:
|
1.67
1.93
|
|
Volume: |
714,332 |
Market Cap: |
90M |
Support:
|
1.26
1.05
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.68
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
1.45  |
Signal(12,26,9): |
0.06 |
|
MA(100): |
1.45 |
Stochastic Oscillator |
%K(14,3):
|
53.33 |
|
MA(250): |
1.89 |
%D(3): |
67.40 |
|
Average Volume(K) |
3-Month: |
36245
|
52-Week |
High:
|
6.09 |
|
10-Days: |
81341 |
Low: |
0.75 |
|
RSI |
RSI(14):
|
57.69 |
Change(%): |
86.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.563 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
32.25 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-67.2 |
Shares Float (M) |
9.68 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
69.32 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
-26.1 |
% Held by Institutions |
2.20 |
|
Forward EPS |
-1.728 |
Gross Profit (p.s.) |
-0.329 |
Shares Short (K) |
1510 |
|
Book Value (p.s.) |
-1.670 |
EBITDA (p.s.) |
-0.334 |
P/E |
-2.79 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.94 |
|
Profit Margin |
-65.04 |
Operating Cash Flow
(M) |
-23.08 |
P/S |
95533016.00 |
|
Operating Margin |
-102.49 |
Levered Free Cash Flow
(M) |
-20.31 |
P/CF |
-2.19 |
|
|
|
|
|
|
